Biomedical Research and Therapy 2198-4093 BioMedPress 10.15419/bmrat.v4i4.163 Correction Biomedical Research and Therapy CORRECTION: Adipose derived stem cell transplantation is better than bone marrow mesenchymal stem cell transplantation in treating hindlimb ischemia in mice Bich Vu Ngoc Thi Phi Lan Thi-Thanh Dao Thuy Thi-Ngan Le Ha Thanh Ta Van Van Pham Phuc * Laboratory of Stem Cell Research and Application, University of Sciences, Vietnam National University, Ho Chi Minh City, Viet Nam Hanoi Medical University, Ha Noi, Vietnam Falcuty of Biology and Biotechnology, University of Sciences, Vietnam National University, Ho Chi Minh City, Vietnam For correspondence: pvphuc@hcmuns.edu.vn

These authors contributed equally to this work

 30 04 2017 4 4 1 2 15 03 2017 20 04 2017 Copyright: © The Author(s) 2017 2017 This article is published with open access by BioMedPress (BMP), Laboratory of Stem Cell Research and Application, Vietnam National University, Ho Chi Minh city, Vietnam This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. Adipose derived stem cell transplantation is better than bone marrow mesenchymal stem cell transplantation in treating hindlimb ischemia in mice

The Figure 5 of the article “Adipose derived stem cell transplantation is better than bone marrow mesenchymal stem cell transplantation in treating hindlimb ischemia in mice” that published in 29 Sept 2016, at Vol 3, Issue 9, from page 844-856 (DOI: 10.7603/s40730-016-0046-0) that lacked the legend for the violet line should be corrected.

 Correction

The Figure 5 of the article “Adipose derived stem cell transplantation is better than bone marrow mesenchymal stem cell transplantation in treating hindlimb ischemia in mice” that published in 29 Sept 2016, at Vol 3, Issue 9, from page 844-856 (DOI: 10.7603/s40730-016-0046-0) that lacked the legend for the violet line should be corrected as: Figure 5 - Corrected

Oxyhemoglobin saturation (SpO2)

SPO2 reached above 95% in AD-MSC and BM-MSC group at day 9, while PBS- and non-treated mice were at day 12.

 Oxyhemoglobin saturation (SpO2)

SPO2 reached above 95% in AD-MSC and BM-MSC group at day 9, while PBS- and non-treated mice were at day 12.

 References